Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 210

1.

Alteration of PON1 activity in adult and childhood obesity and its relation to adipokine levels.

Seres I, Bajnok L, Harangi M, Sztanek F, Koncsos P, Paragh G.

Adv Exp Med Biol. 2010;660:129-42. doi: 10.1007/978-1-60761-350-3_12. Review.

PMID:
20221876
2.

Human paraoxonase-1 activity in childhood obesity and its relation to leptin and adiponectin levels.

Koncsos P, Seres I, Harangi M, Illyés I, Józsa L, Gönczi F, Bajnok L, Paragh G.

Pediatr Res. 2010 Mar;67(3):309-13. doi: 10.1203/PDR.0b013e3181c9fb66.

PMID:
19915520
3.

Relationship of serum resistin level to traits of metabolic syndrome and serum paraoxonase 1 activity in a population with a broad range of body mass index.

Bajnok L, Seres I, Varga Z, Jeges S, Peti A, Karanyi Z, Juhasz A, Csongradi E, Mezosi E, Nagy EV, Paragh G.

Exp Clin Endocrinol Diabetes. 2008 Nov;116(10):592-9. doi: 10.1055/s-2008-1065350. Epub 2008 May 9.

PMID:
18465683
4.

Favorable effect of short-term lifestyle intervention on human paraoxonase-1 activity and adipokine levels in childhood obesity.

Koncsos P, Seres I, Harangi M, Páll D, Józsa L, Bajnok L, Nagy EV, Paragh G.

J Am Coll Nutr. 2011 Oct;30(5):333-9.

PMID:
22081619
5.

Relationship of adiponectin to serum paraoxonase 1.

Bajnok L, Csongradi E, Seres I, Varga Z, Jeges S, Peti A, Karanyi Z, Juhasz A, Mezosi E, Nagy EV, Paragh G.

Atherosclerosis. 2008 Mar;197(1):363-7. Epub 2007 Jul 12.

PMID:
17624354
6.

Relationship of endogenous hyperleptinemia to serum paraoxonase 1, cholesteryl ester transfer protein, and lecithin cholesterol acyltransferase in obese individuals.

Bajnok L, Seres I, Varga Z, Jeges S, Peti A, Karanyi Z, Juhasz A, Csongradi E, Mezosi E, Nagy EV, Paragh G.

Metabolism. 2007 Nov;56(11):1542-9.

PMID:
17950106
7.

Paraoxonase (PON)-1 activity in overweight and obese children and adolescents: association with obesity-related inflammation and oxidative stress.

Krzystek-Korpacka M, Patryn E, Hotowy K, Czapińska E, Majda J, Kustrzeba-Wójcicka I, Noczyńska A, Gamian A.

Adv Clin Exp Med. 2013 Mar-Apr;22(2):229-36.

8.

High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus.

Dullaart RP, de Vries R, Sluiter WJ, Voorbij HA.

Clin Endocrinol (Oxf). 2009 Feb;70(2):221-6. doi: 10.1111/j.1365-2265.2008.03306.x.

PMID:
18505467
9.

[Adipokines: adiponectin, leptin, resistin and coronary heart disease risk].

Kopff B, Jegier A.

Przegl Lek. 2005;62 Suppl 3:69-72. Review. Polish.

PMID:
16521924
10.

Differential adipokine receptor expression on circulating leukocyte subsets in lean and obese children.

Keustermans G, van der Heijden LB, Boer B, Scholman R, Nuboer R, Pasterkamp G, Prakken B, de Jager W, Kalkhoven E, Janse AJ, Schipper HS.

PLoS One. 2017 Oct 26;12(10):e0187068. doi: 10.1371/journal.pone.0187068. eCollection 2017.

11.

Relationship of adipokine to insulin sensitivity and glycemic regulation in obese women--the effect of body weight reduction by caloric restriction.

Golubović MV, Dimić D, Antić S, Radenković S, Djindjić B, Jovanović M.

Vojnosanit Pregl. 2013 Mar;70(3):284-91.

PMID:
23607240
12.

Serum paraoxonase enzyme activity and oxidative stress in obese subjects.

Aslan M, Horoz M, Sabuncu T, Celik H, Selek S.

Pol Arch Med Wewn. 2011 Jun;121(6):181-6.

13.

The prediction role of indexes of circulating adipokines for common anthropometric and nutritional characteristics of obesity in the obese Central European population.

Bienertová-Vašků J, Novák J, Zlámal F, Forejt M, Havlenová S, Jackowská A, Tomandl J, Tomandlová M, Šplíchal Z, Vašků A.

Eat Behav. 2014 Apr;15(2):244-51. doi: 10.1016/j.eatbeh.2014.03.001. Epub 2014 Mar 15.

PMID:
24854812
14.
15.

Effect of nutritional status on human paraoxonase-1 activity in patients with chronic kidney disease.

Sztanek F, Seres I, Harangi M, Lőcsey L, Koncsos P, Paragh G.

Kidney Blood Press Res. 2012;36(1):310-9. doi: 10.1159/000343383. Epub 2012 Dec 12.

16.

Molecular aspects of adipokine-bone interactions.

Magni P, Dozio E, Galliera E, Ruscica M, Corsi MM.

Curr Mol Med. 2010 Aug;10(6):522-32. Review.

PMID:
20642443
17.

Impaired paraoxonase-1 status in obese children. Relationships with insulin resistance and metabolic syndrome.

Ferré N, Feliu A, García-Heredia A, Marsillach J, París N, Zaragoza-Jordana M, Mackness B, Mackness M, Escribano J, Closa-Monasterolo R, Joven J, Camps J.

Clin Biochem. 2013 Dec;46(18):1830-6. doi: 10.1016/j.clinbiochem.2013.08.020. Epub 2013 Sep 10.

PMID:
24028901
18.

Synovial fluid levels of adipokines in osteoarthritis: Association with local factors of inflammation and cartilage maintenance.

Gross JB, Guillaume C, Gégout-Pottie P, Mainard D, Presle N.

Biomed Mater Eng. 2014;24(1 Suppl):17-25. doi: 10.3233/BME-140970.

PMID:
24928914
19.

Abnormal adipokines associated with various types of obesity in Chinese children and adolescents.

Zhang M, Zhao X, Li M, Cheng H, Hou D, Wen Y, Katherine C, Mi J.

Biomed Environ Sci. 2011 Feb;24(1):12-21. doi: 10.3967/0895-3988.2011.01.002.

20.

Association of chemerin with oxidative stress, inflammation and classical adipokines in non-diabetic obese patients.

Fülöp P, Seres I, Lőrincz H, Harangi M, Somodi S, Paragh G.

J Cell Mol Med. 2014 Jul;18(7):1313-20. doi: 10.1111/jcmm.12282. Epub 2014 Apr 6.

Supplemental Content

Support Center